Company intelligence / Profile preview

Welgene Biotech Co., Ltd.

Ownership: Private
Development stage: Commercial

Overview

Welgene Biotech provides genetic testing services and products, with a focus on DNA microarray, Next Generation Sequencing, and real-time quantitative PCR technologies. The company has obtained TAF ISO17025, TFDA LDTS, and original factory certifications for its testing services.

Therapeutic areas: Rare DiseasesWomen's Health
Modalities: Genetic testing servicesDNA microarrayNext Generation Sequencingreal-time quantitative polymerase chain reaction (PCR)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Welgene Biotech Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Welgene Biotech Co., Ltd..

Explore the full profile